View Archive »
About The Cover
The cover for issue 33 of Oncotarget features Figure 7A, "Anti-STn ADCs impede OvCa xenograft growth in vivo and target STn+ cells," from Starbuck, et al.
|
|
Table of Contents
Research Papers
|
| SRC/ABL inhibition disrupts CRLF2driven signaling to induce cell death in Bcell acute lymphoblastic leukemia |
|
https://doi.org/10.18632/oncotarget.25089
|
| 22872-22885 |
|
| Analysis of KIT gene mutations in patients with melanoma of the head and neck mucosa: a retrospective clinical report |
|
https://doi.org/10.18632/oncotarget.25094
|
| 22886-22894 |
|
| Comprehensive molecular analysis based on somatic copy number alterations in intramucosal colorectal neoplasias and early invasive colorectal cancers |
|
https://doi.org/10.18632/oncotarget.25112
|
| 22895-22906 |
|
| Involvement of SNPs in miR3117 and miR3689d2 in childhood acute lymphoblastic leukemia risk |
|
https://doi.org/10.18632/oncotarget.25144
|
| 22907-22914 |
|
| YdjC chitooligosaccharide deacetylase homolog induces keratin reorganization in lung cancer cells: involvement of interaction between YDJC and CDC16 |
|
https://doi.org/10.18632/oncotarget.25145
|
| 22915-22928 |
|
| Disturbed alternative splicing of FIR PUF60 directed cyclin E overexpression in esophageal cancers |
|
https://doi.org/10.18632/oncotarget.25149
|
| 22929-22944 |
|
| Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expression |
|
https://doi.org/10.18632/oncotarget.25159
|
| 22945-22959 |
|
| Preclinical evaluation of a GFRA1 targeted antibodydrug conjugate in breast cancer |
|
https://doi.org/10.18632/oncotarget.25160
|
| 22960-22975 |
|
| Carbon ion radiotherapy for inoperable pediatric osteosarcoma |
|
https://doi.org/10.18632/oncotarget.25165
|
| 22976-22985 |
|
| Combination of two antitubulin agents eribulin and paclitaxel enhances antitumor effects on triplenegative breast cancer through mesenchymalepithelial transition |
|
https://doi.org/10.18632/oncotarget.25184
|
| 22986-23002 |
|
| Bromodomain protein BRD4 inhibitor JQ1 regulates potential prognostic molecules in advanced renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25190
|
| 23003-23017 |
|
| Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST |
|
https://doi.org/10.18632/oncotarget.25195
|
| 23018-23028 |
|
| Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for cMYC and wildtype p53 in determining the degree of tumour selectivity |
|
https://doi.org/10.18632/oncotarget.25196
|
| 23029-23046 |
|
| Riskstratified surveillance protocol improves costeffectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma |
|
https://doi.org/10.18632/oncotarget.25198
|
| 23047-23057 |
|
| Oncodriver inhibition and CD4+ Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies |
|
https://doi.org/10.18632/oncotarget.25208
|
| 23058-23077 |
|
| Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.25212
|
| 23078-23090 |
|
| Abundance of TRAIL attenuated by HIF2α and cFLIP affects malignancy in renal cell carcinomas |
|
https://doi.org/10.18632/oncotarget.25214
|
| 23091-23101 |
|
| A targeted transforming growth factorbeta TGFβ blocker TTB inhibits tumor growth and metastasis |
|
https://doi.org/10.18632/oncotarget.24562
|
| 23102-23113 |
|
| Association of increased primary breast tumor AGR2 with decreased diseasespecific survival |
|
https://doi.org/10.18632/oncotarget.25225
|
| 23114-23125 |
|
| Differential prognostic impact of interleukin34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypes |
|
https://doi.org/10.18632/oncotarget.25226
|
| 23126-23148 |
|
| SB202190 inhibits endothelial cell apoptosis via induction of autophagy and heme oxygenase1 |
|
https://doi.org/10.18632/oncotarget.25234
|
| 23149-23163 |
|
| Preoperative tumor size is associated with deep myometrial invasion and lymph node metastases and is a negative prognostic indicator for patients with endometrial carcinoma |
|
https://doi.org/10.18632/oncotarget.25248
|
| 23164-23172 |
|
| Gene expression profiling in prognosis of distant recurrence in HRpositive and HER2negative breast cancer patients |
|
https://doi.org/10.18632/oncotarget.25258
|
| 23173-23182 |
|
| RPGR protein complex regulates proteasome activity and mediates storeoperated calcium entry |
|
https://doi.org/10.18632/oncotarget.25259
|
| 23183-23197 |
|
| DGCspecific RHOA mutations maintained cancer cell survival and promoted cell migration via ROCK inactivation |
|
https://doi.org/10.18632/oncotarget.25269
|
| 23198-23207 |
|
| PKD1 is a potential biomarker and therapeutic target in triplenegative breast cancer |
|
https://doi.org/10.18632/oncotarget.25292
|
| 23208-23219 |
|
| MAP4K4 controlled integrin β1 activation and cMet endocytosis are associated with invasive behavior of medulloblastoma cells |
|
https://doi.org/10.18632/oncotarget.25294
|
| 23220-23236 |
|
| Chloride intracellular channel 1 as a switch among tumor behaviors in human esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25296
|
| 23237-23252 |
|
| miR34a miR424 and miR513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation |
|
https://doi.org/10.18632/oncotarget.25298
|
| 23253-23263 |
|
| Cytokeratin 8/18 protects breast cancer cell lines from TRAILinduced apoptosis |
|
https://doi.org/10.18632/oncotarget.25297
|
| 23264-23273 |
|
| The effects of restricted glycolysis on stemcell like characteristics of breast cancer cells |
|
https://doi.org/10.18632/oncotarget.25299
|
| 23274-23288 |
|
| Treatment of ovarian cancer by targeting the tumor stem cellassociated carbohydrate antigen SialylThomsennouveau |
|
https://doi.org/10.18632/oncotarget.25289
|
| 23289-23305 |
Reviews
|
| Cancer stem cells of hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.24623
|
| 23306-23314 |
Case Reports
|
| A case of ALKrearranged non–small cell lung cancer that responded to ceritinib after development of resistance to alectinib |
|
https://doi.org/10.18632/oncotarget.25143
|
| 23315-23319 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
